MLN4924-Inhibitor of Nedd8-activating enzyme (NAE)

MLN4924-Inhibitor of Nedd8-activating enzyme (NAE)
Trade Name
Orphan Indication Acute myeloid leukemia
USA Market Approval USA
USA Designation Date 2011-02-04 00:00:00
Sponsor Millennium Pharmaceuticals;40 Landsdowne St.;Cambridge, Massachusetts, 02139
Related Access Program
Children’s Hospital Los Angeles – Acute myeloid leukemia Jazz Pharmaceuticals – Secondary AML Celator Pharmaceuticals – Secondary AML University of California, San Francisco – Acute myeloid leukemia Emory University – Acute myeloid leukemia